CMS has added two drugs/biologics (HCPCS C9292 Injection perttzumab, 10 mg and HCPCS C9293 Injection, glucarpidase, 10 units) to the ASC list of payable drugs/biologics effective Oct. 1, 2012.
The list of covered ancillary services for 2012 has been updated on ASCA’s website here.
Related Articles on Coding, Billing and Collections:
How to Successfully Handle Out-of-Network Contracts in ASCs
Maine Physician Pays $321K to Settle False Billing Claims
5 Tactics to Negotiate Bundled Payments for Surgery Centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
